Ticker Launch

SPAC · Merger completed

MedTech Acquisition Corp

Business combination with TriSalus Life Sciences

MedTech Acquisition Corp is a blank-check company (SPAC) that completed its initial public offering on Dec 21, 2020, listing on Nasdaq. It completed its business combination with TriSalus Life Sciences on Aug 10, 2023; the combined company is TriSalus Life Sciences, Inc. (TLSI). Ellenoff Grossman & Schole advised the SPAC and Greenberg Traurig advised the underwriters on the IPO.

TriSalus Life Sciences is an oncology therapeutics company combining immunotherapy with a drug delivery technology for patients with liver and pancreatic tumors. Its TriSalus Platform uses PEDD to administer investigational immunotherapy in clinical trials across multiple indications.

Status
Merger completed
IPO date
Dec 21, 2020
IPO exchange
Nasdaq
Target
TriSalus Life Sciences (Legacy TriSalus)
Announced
Nov 14, 2022
Closed
Aug 10, 2023
Combined company
TriSalus Life Sciences, Inc. (TLSI)
SPAC counsel (IPO)
Ellenoff Grossman & Schole
Underwriters' counsel (IPO)
Greenberg Traurig

More on this SPAC for subscribers

Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.

Then $99/month or $999/year. Cancel anytime.

Filings

Other deSPACs that closed in 2023